AAG
LLY icon

Armstrong Advisory Group’s Eli Lilly LLY Stock Holding History

Armstrong Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.06M Sell
6,723
-28
-0.4% -$28.6K 0.49% 29
2026
Q1 		$6.21M Sell
6,751
-1,442
-18% -$1.46M 0.42% 30
2025
Q4 		$8.8M Sell
8,193
-577
-7% -$552K 0.6% 29
2025
Q3 		$6.69M Buy
8,770
+3,062
+54% +$2.28M 0.47% 30
2025
Q2 		$4.45M Sell
5,708
-284
-5% -$221K 0.34% 36
2025
Q1 		$4.63M Hold
5,992
– – 0.37% 33
2024
Q4 		$4.63M Sell
5,992
-38
-0.6% -$31.5K 0.37% 33
2024
Q3 		$5.34M Sell
6,030
-191
-3% -$172K 0.44% 32
2024
Q2 		$5.63M Sell
6,221
-202
-3% -$162K 0.5% 29
2024
Q1 		$3.74M Hold
6,423
– – 0.36% 34
2023
Q4 		$3.74M Buy
6,423
+6
+0.1% +$3.5K 0.36% 34
2023
Q3 		$3.45M Sell
6,417
-36
-0.6% -$18.6K 0.38% 31
2023
Q2 		$3.03M Sell
6,453
-106
-2% -$44.5K 0.32% 32
2023
Q1 		$2.25M Sell
6,559
-45
-0.7% -$15.2K 0.27% 33
2022
Q4 		$2.42M Buy
+6,604
New +$2.34M 0.32% 37

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Armstrong Advisory Group's LLY Position: Q2 2026 in Review

Armstrong Advisory Group reduced its Eli Lilly (LLY) stake by 0.41% in Q2 2026, selling an estimated $28.6K and leaving 6,723 shares worth $8.06M. The position accounts for 0.49% of the portfolio, ranked #29.

Armstrong Advisory Group first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.8M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Armstrong Advisory Group held 6,723 shares of Eli Lilly worth $8.06M as of Q2 2026.
  • Armstrong Advisory Group sold 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 0.49% of Armstrong Advisory Group's portfolio in Q2 2026, its #29 holding.
  • Armstrong Advisory Group first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Eli Lilly position peaked at $8.8M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.